[Survival in HIV-1 patients receiving antiretroviral therapy in Morocco].

Background: The purpose was to study factors associated with the survival of HIV-1 patients receiving antiretroviral therapy in Morocco.

Material And Method: This was a retrospective study of a cohort of 182 HIV-1 patients receiving antiretroviral therapy in the department of dermatology venereology at the Military Instruction Hospital Mohamed V in Rabat during the period from 1 January 2006 to 1 January 2017. Death of any cause during the study period was considered to be the result of HIV infection.